- Home
- AMIX vs PRFX Comparison
AMIX vs PRFX Comparison
Compare AMIX & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMIX
- PRFX
- Stock Information
- Founded
- AMIX 2014
- PRFX 2007
- Country
- AMIX United States
- PRFX Israel
- Employees
- AMIX N/A
- PRFX N/A
- Industry
- AMIX
- PRFX Biotechnology: Pharmaceutical Preparations
- Sector
- AMIX
- PRFX Health Care
- Exchange
- AMIX NYSE
- PRFX Nasdaq
- Market Cap
- AMIX 3.5M
- PRFX 2.9M
- IPO Year
- AMIX N/A
- PRFX 2020
- Fundamental
- Price
- AMIX $1.40
- PRFX $1.41
- Analyst Decision
- AMIX Strong Buy
- PRFX Hold
- Analyst Count
- AMIX 1
- PRFX 1
- Target Price
- AMIX $5.00
- PRFX N/A
- AVG Volume (30 Days)
- AMIX 2.6M
- PRFX 180.5K
- Earning Date
- AMIX 08-12-2025
- PRFX 08-14-2025
- Dividend Yield
- AMIX N/A
- PRFX N/A
- EPS Growth
- AMIX N/A
- PRFX N/A
- EPS
- AMIX N/A
- PRFX N/A
- Revenue
- AMIX N/A
- PRFX N/A
- Revenue This Year
- AMIX N/A
- PRFX N/A
- Revenue Next Year
- AMIX N/A
- PRFX N/A
- P/E Ratio
- AMIX N/A
- PRFX N/A
- Revenue Growth
- AMIX N/A
- PRFX N/A
- 52 Week Low
- AMIX $1.14
- PRFX $1.25
- 52 Week High
- AMIX $42.40
- PRFX $16.63
- Technical
- Relative Strength Index (RSI)
- AMIX 47.58
- PRFX 33.30
- Support Level
- AMIX $1.32
- PRFX $1.25
- Resistance Level
- AMIX $1.59
- PRFX $1.48
- Average True Range (ATR)
- AMIX 0.19
- PRFX 0.10
- MACD
- AMIX 0.04
- PRFX -0.02
- Stochastic Oscillator
- AMIX 21.71
- PRFX 21.74
About AMIX AUTONOMIX MEDICAL INC
Autonomix Medical Inc is a development-stage medical device development company focused on advancing technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.